| 摘要 |
The present invention provides a compound of chemical formula I, a pharmaceutically acceptable salt or a solvent thereof, and a pharmaceutical composition for treating cancer and a pharmaceutical composition for a cancer radiotherapy sensitizer, containing the same. In chemical formula I, -R1 is C1-C3 alkoxy, =O, or –OH; and -R2 is 5-membered or 6-membered heteroaryl containing 1-2 hetero atoms selected among nitrogen and oxygen, wherein a carbon of heteroaryl is selectively substituted with C1-C3 alkyl, C1-C3 alkoxy, or hydroxy. [Reference numerals] (AA) Control group (0uM);(BB) Ciglitazone (10uM) |
